Nwam LLC Has $277,000 Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Nwam LLC lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 88.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,043 shares of the company’s stock after selling 22,689 shares during the quarter. Nwam LLC’s holdings in GE HealthCare Technologies were worth $277,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of GEHC. Norges Bank bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $229,052,000. Capital Research Global Investors lifted its stake in shares of GE HealthCare Technologies by 2.8% in the 4th quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock valued at $3,969,975,000 after acquiring an additional 1,401,566 shares during the last quarter. Perpetual Ltd bought a new position in shares of GE HealthCare Technologies in the 1st quarter valued at $96,135,000. Stonegate Investment Group LLC raised its position in GE HealthCare Technologies by 3,555.0% during the 4th quarter. Stonegate Investment Group LLC now owns 654,391 shares of the company’s stock worth $50,598,000 after purchasing an additional 636,487 shares during the last quarter. Finally, International Assets Investment Management LLC raised its position in GE HealthCare Technologies by 8,158.8% during the 4th quarter. International Assets Investment Management LLC now owns 605,290 shares of the company’s stock worth $46,801,000 after purchasing an additional 597,961 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on GEHC shares. The Goldman Sachs Group started coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 target price for the company. Citigroup raised their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Mizuho lowered their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Evercore ISI raised their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Finally, Bank of America lowered their target price on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Five research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $94.09.

GE HealthCare Technologies Stock Down 0.6 %

Shares of GEHC traded down $0.51 during trading hours on Friday, hitting $80.44. The stock had a trading volume of 2,428,375 shares, compared to its average volume of 2,743,324. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83. The firm has a 50 day simple moving average of $78.74 and a 200-day simple moving average of $82.01. The firm has a market capitalization of $36.72 billion, a P/E ratio of 23.52, a price-to-earnings-growth ratio of 2.91 and a beta of 1.20. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, meeting the consensus estimate of $0.90. The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period last year, the business posted $0.85 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a $0.03 dividend. The ex-dividend date is Friday, July 19th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Insider Activity

In other news, insider Frank R. Jimenez bought 1,315 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, May 1st. The stock was bought at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the purchase, the insider now directly owns 75,796 shares in the company, valued at approximately $5,799,909.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Frank R. Jimenez purchased 1,315 shares of the business’s stock in a transaction on Wednesday, May 1st. The stock was acquired at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the purchase, the insider now owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Jan Makela sold 20,227 shares of GE HealthCare Technologies stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the transaction, the chief executive officer now owns 63,348 shares of the company’s stock, valued at approximately $5,167,296.36. The disclosure for this sale can be found here. Insiders sold a total of 90,482 shares of company stock worth $7,369,137 in the last three months. Company insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.